StockData
Alumis Inc. logo

Alumis Inc. (ALMS) stock

ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$4.39−0.45 (-9.19%)

Close on Nov 18, 2026Market cap $568.87MP/E –Yield –

Alumis net income

Net income is the profit left for shareholders after every expense, interest and tax.

Alumis's net income for the twelve months ending Jun 30, 2026 was -$438.96M. For fiscal 2025 it was -$243.33M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$243.33M–
FY2024Dec 31, 2024-$294.23M–
FY2023Dec 31, 2023-$154.99M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$142.22M-339.7%
Q1 FY2026Mar 31, 2026-$93.05M–
Q4 FY2025Dec 31, 2025-$92.93M–
Q3 FY2025Sep 30, 2025-$110.75M–
Q2 FY2025Jun 30, 2025$59.32M–
Q1 FY2025Mar 31, 2025-$98.96M–
Q4 FY2024Dec 31, 2024-$94.76M–
Q3 FY2024Sep 30, 2024-$93.12M–
Q2 FY2024Jun 30, 2024-$56.51M–
Q1 FY2024Mar 31, 2024-$49.85M–
Q4 FY2023Dec 31, 2023-$39.30M–
Q3 FY2023Sep 30, 2023-$43.38M–
Q2 FY2023Jun 30, 2023-$36.29M–
Q1 FY2023Mar 31, 2023-$36.03M–

More Alumis figures

See a number that looks wrong?